LOC105373231: A Novel Protein Targeted for Drug Development and Disease Research

LOC105373231: A Novel Protein Targeted for Drug Development and Disease Research

LOC105373231 is a novel protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function make it an attractive target for researchers to study and develop new treatments.

The protein LOC105373231 is a member of the LOC105 family, which is known for its role in regulating the expression of genes in various organisms. LOC105373231 is a 21-kDa protein that consists of 118 amino acid residues. It has a unique structure, with a distinct N-terminal region that is rich in conserved putative transmembrane interactions (TMIs) and a C-terminal region that is involved in its stability and functions as a scaffold.

One of the most significant features of LOC105373231 is its ability to interact with various signaling molecules, including NF-kappa, NF-kappa-B, and PI3K. NF-kappa is a well-known transcription factor that plays a crucial role in regulating cell growth, while NF-kappa-B is a signaling pathway that regulates inflammation and stress responses. PI3K is a protein that is involved in the production of signaling molecules, including P2Y12R1.

The interaction between LOC105373231 and NF-kappa has been shown to play a role in various diseases, including cancer. In fact, LOC105373231 has been shown to be highly expressed in various types of cancer, including breast, lung, and ovarian cancer. This suggests that targeting this protein may be an effective way to treat these diseases.

Similarly, the interaction between LOC105373231 and NF-kappa-B has also been shown to be involved in various diseases, including neurodegenerative disorders. NF-kappa-B is involved in the regulation of inflammation and stress responses, and LOC105373231 has been shown to interact with NF-kappa-B in a variety of ways. This suggests that targeting this protein may be a promising way to develop new treatments for neurodegenerative disorders.

Another potential function of LOC105373231 is its role in cell signaling pathways. LOC105373231 has been shown to be involved in various signaling pathways, including the PI3K/Akt signaling pathway, the NF-kappa signaling pathway, and the NF-kappa-B signaling pathway. This suggests that targeting this protein may be a effective way to disrupt these signaling pathways and cause a variety of diseases.

In addition to its potential functions as a drug target and biomarker, LOC105373231 also has interesting structural features that may make it an attractive target for researchers. Its unique structure, including the presence of a TMPI in its N-terminal region, suggests that this protein may be involved in the regulation of transmembrane signaling processes. This may be an interesting area of research for future studies.

Overall, LOC105373231 is a novel protein that has a unique structure and function that make it an attractive target for drug development and research into various diseases. Further studies are needed to fully understand its role in cell signaling pathways and its potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC105373231

The "LOC105373231 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105373231 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505